Hoge Stephen — SEC Form 4 filings
SEC reporting owner CIK 1760669. 42 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 42 filings on record, filed 2024-01-17 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 26 legs across 25 filings — 521,824 shares, $41,870,084 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 126.
- Largest priced transaction: sale of 160,009 shares @ $48.84 ($7,814,840) in Moderna, Inc., filed 2026-02-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | President | 42 | — | 26 legs · 521,824 sh · $41,870,084 | 126 |
Form 4 filings — Hoge Stephen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 76,453 @ $12.21 · Sale (S): 40,294 @ $144.13 · Option exercise (M): 76,452 @ $12.21 · Sale (S): 40,281 @ $146.07 · Option exercise (M): 76,453 (derivative) @ $0 · Option exercise (M): 76,452 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 9,283 · Tax withholding (F): 4,489 @ $140.34 · Option exercise (M): 9,283 (derivative) @ $0 | EDGAR |
| 2026-08-31 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,437 · Tax withholding (F): 695 @ $149.66 · Option exercise (M): 611 · Tax withholding (F): 296 @ $142.77 · Option exercise (M): 1,437 (derivative) @ $0 · Option exercise (M): 611 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 37,226 @ $19.15 · Option exercise (M): 16,110 @ $19.15 · Sale (S): 53,336 @ $67.60 · Option exercise (M): 37,226 (derivative) @ $0 · Option exercise (M): 16,110 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 37,226 @ $19.15 · Option exercise (M): 16,110 @ $19.15 · Sale (S): 53,336 @ $51.37 · Option exercise (M): 37,226 (derivative) @ $0 · Option exercise (M): 16,110 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 9,282 · Tax withholding (F): 4,488 @ $47.19 · Option exercise (M): 9,282 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,437 · Tax withholding (F): 695 @ $47.03 · Option exercise (M): 610 · Tax withholding (F): 295 @ $47.61 · Option exercise (M): 1,437 (derivative) @ $0 · Option exercise (M): 610 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 37,226 @ $19.15 · Option exercise (M): 16,110 @ $19.15 · Sale (S): 53,336 @ $48.40 · Option exercise (M): 37,226 (derivative) @ $0 · Option exercise (M): 16,110 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 652 · Tax withholding (F): 316 @ $51.71 · Option exercise (M): 611 · Tax withholding (F): 296 @ $51.71 · Option exercise (M): 1,436 · Tax withholding (F): 695 @ $51.71 · +8 more | EDGAR |
| 2026-02-25 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 111,679 @ $19.15 · Option exercise (M): 48,330 @ $19.15 · Sale (S): 160,009 @ $48.84 · Option exercise (M): 111,679 (derivative) @ $0 · Option exercise (M): 48,330 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 4,884 @ $0 · Tax withholding (F): 2,362 @ $41.99 | EDGAR |
| 2025-12-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 652 · Tax withholding (F): 316 @ $25.98 · Option exercise (M): 652 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,437 · Tax withholding (F): 695 @ $24.75 · Option exercise (M): 610 · Tax withholding (F): 295 @ $25.01 · Option exercise (M): 1,437 (derivative) @ $0 · Option exercise (M): 610 (derivative) @ $0 | EDGAR |
| 2025-09-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 651 · Tax withholding (F): 315 @ $24.47 · Option exercise (M): 651 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,437 · Tax withholding (F): 695 @ $24.73 · Option exercise (M): 611 · Tax withholding (F): 296 @ $25.10 · Option exercise (M): 1,437 (derivative) @ $0 · Option exercise (M): 611 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 652 · Tax withholding (F): 316 @ $26.93 · Option exercise (M): 652 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 1,436 · Tax withholding (F): 695 @ $26.26 · Option exercise (M): 610 · Tax withholding (F): 295 @ $26.76 · Option exercise (M): 1,436 (derivative) @ $0 · Option exercise (M): 610 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 652 · Tax withholding (F): 316 @ $31.09 · Option exercise (M): 611 · Tax withholding (F): 296 @ $31.09 · Option exercise (M): 652 (derivative) @ $0 · Option exercise (M): 611 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-28 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 5,746 · Tax withholding (F): 2,779 @ $33.58 · Option exercise (M): 5,746 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 5,734 @ $0 · Tax withholding (F): 2,771 @ $30.93 | EDGAR |
| 2025-02-10 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 523 · Tax withholding (F): 281 @ $33.61 · Option exercise (M): 523 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 651 · Sale (S): 314 @ $43.30 · Option exercise (M): 651 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 610 · Sale (S): 291 @ $42.79 · Option exercise (M): 610 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 523 · Sale (S): 277 @ $46.10 · Option exercise (M): 523 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 652 · Sale (S): 318 @ $76.99 · Option exercise (M): 652 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 611 · Sale (S): 300 @ $78.03 · Option exercise (M): 611 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 522 · Sale (S): 254 @ $84.10 · Option exercise (M): 522 (derivative) @ $0 | EDGAR |
| 2024-07-16 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $121.12 | EDGAR |
| 2024-06-18 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $138.16 | EDGAR |
| 2024-06-04 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 651 · Sale (S): 339 @ $140.72 · Option exercise (M): 651 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 610 · Sale (S): 341 @ $144.50 · Option exercise (M): 610 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $127.49 | EDGAR |
| 2024-05-13 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 522 · Sale (S): 255 @ $120.96 · Option exercise (M): 522 (derivative) @ $0 | EDGAR |
| 2024-04-16 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $105.02 | EDGAR |
| 2024-03-19 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $103.17 | EDGAR |
| 2024-03-05 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 652 · Sale (S): 309 @ $94.34 · Option exercise (M): 652 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 2,411 · Option exercise (M): 2,442 · Sale (S): 2,388 @ $94.57 · Option exercise (M): 2,411 (derivative) @ $0 · Option exercise (M): 2,442 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 43,894 (derivative) @ $0 · Grant/award (A): 22,987 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $100 | EDGAR |
| 2024-02-16 | 4 | Moderna, Inc. (MRNA) | Grant/award (A): 22,694 @ $0 · Sale (S): 10,542 @ $88.88 | EDGAR |
| 2024-02-13 | 4 | Moderna, Inc. (MRNA) | Option exercise (M): 522 · Sale (S): 304 @ $86.23 · Option exercise (M): 522 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | Moderna, Inc. (MRNA) | Sale (S): 15,000 @ $103.90 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760669 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →